In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, Eris Lifesciences has informed that the Analyst / Institutional Investor Meeting will be held on January 07, 2022 with UTI Mutual Fund through Zoom Call. The schedule is indicative and is subject to changes necessitated by any unforeseen developments. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
The above information is a part of company’s filings submitted to BSE.
